These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 31741498)

  • 1. Re: Musings on malaria morbidity and mortality after the new Mosquirix
    Asante KP; Malm K; Darko DM; Koram KA
    Ghana Med J; 2019 Sep; 53(3):252-253. PubMed ID: 31741498
    [No Abstract]   [Full Text] [Related]  

  • 2. Musings on malaria morbidity and mortality after the new Mosquirix
    Sackey AH
    Ghana Med J; 2019 Jun; 53(2):187-188. PubMed ID: 31481817
    [No Abstract]   [Full Text] [Related]  

  • 3. Mosquirix (RTS,S): a novel vaccine for the prevention of Plasmodium falciparum malaria.
    Wilby KJ; Lau TT; Gilchrist SE; Ensom MH
    Ann Pharmacother; 2012 Mar; 46(3):384-93. PubMed ID: 22408046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Landmark green light for Mosquirix malaria vaccine.
    Morrison C
    Nat Biotechnol; 2015 Oct; 33(10):1015-6. PubMed ID: 26448075
    [No Abstract]   [Full Text] [Related]  

  • 5. RTS,S/AS01E malaria vaccine (MoSQUIRIX*) Children living in malaria-endemic regions: little efficacy, poorly documented harms.
    Prescrire Int; 2017 Jan; 26(178):5-8. PubMed ID: 30730633
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The case for PfEMP1-based vaccines to protect pregnant women against Plasmodium falciparum malaria.
    Hviid L
    Expert Rev Vaccines; 2011 Oct; 10(10):1405-14. PubMed ID: 21988306
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vaccines for preventing malaria.
    Graves P; Gelband H
    Cochrane Database Syst Rev; 2000; (2):CD000129. PubMed ID: 10796492
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy trial of malaria vaccine SPf66 in Gambian infants.
    D'Alessandro U; Leach A; Drakeley CJ; Bennett S; Olaleye BO; Fegan GW; Jawara M; Langerock P; George MO; Targett GA
    Lancet; 1995 Aug; 346(8973):462-7. PubMed ID: 7637479
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Malaria vaccine development: progress and challenges.
    Reed ZH; Friede M; Kieny MP
    Curr Mol Med; 2006 Mar; 6(2):231-45. PubMed ID: 16515513
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The development of malaria vaccines: SPf66--what next?
    Tanner M; Alonso PL
    Schweiz Med Wochenschr; 1996 Jul; 126(27-28):1210-5. PubMed ID: 8766632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and parasitological studies on immunity to Plasmodium falciparum malaria in children.
    Høgh B
    Scand J Infect Dis Suppl; 1996; 102():1-53. PubMed ID: 9060051
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RTS,S/AS01 malaria vaccine and child mortality.
    Müller O; Tozan Y; Becher H
    Lancet; 2015 Oct; 386(10005):1736. PubMed ID: 26545434
    [No Abstract]   [Full Text] [Related]  

  • 13. The march toward malaria vaccines.
    Hoffman SL; Vekemans J; Richie TL; Duffy PE
    Vaccine; 2015 Nov; 33 Suppl 4(Suppl 4):D13-23. PubMed ID: 26324116
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccination with chemically attenuated Plasmodium falciparum asexual blood-stage parasites induces parasite-specific cellular immune responses in malaria-naïve volunteers: a pilot study.
    Stanisic DI; Fink J; Mayer J; Coghill S; Gore L; Liu XQ; El-Deeb I; Rodriguez IB; Powell J; Willemsen NM; De SL; Ho MF; Hoffman SL; Gerrard J; Good MF
    BMC Med; 2018 Oct; 16(1):184. PubMed ID: 30293531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Falciparum malaria in children.
    Newton CR
    Curr Opin Pediatr; 1996 Feb; 8(1):16-20. PubMed ID: 8680508
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasmodium falciparum: malaria morbidity is associated with specific merozoite surface antigen 2 genotypes.
    Engelbrecht F; Felger I; Genton B; Alpers M; Beck HP
    Exp Parasitol; 1995 Aug; 81(1):90-6. PubMed ID: 7628572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA vaccines for malaria: the past, the present, & the future.
    Doolan DL; Hedstrom RC; Wang R; Sedegah M; Scheller LF; Hobart P; Norman JA; Hoffman SL
    Indian J Med Res; 1997 Aug; 106():109-19. PubMed ID: 9291681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immune response to the hepatitis B antigen in the RTS,S/AS01 malaria vaccine, and co-administration with pneumococcal conjugate and rotavirus vaccines in African children: A randomized controlled trial.
    Valéa I; Adjei S; Usuf E; Traore O; Ansong D; Tinto H; Owusu Boateng H; Leach A; Mwinessobaonfou Some A; Buabeng P; Vekemans J; Nana LA; Kotey A; Vandoolaeghe P; Ouedraogo F; Sambian D; Lievens M; Tahita MC; Rettig T; Jongert E; Lompo P; Idriss A; Borys D; Ouedraogo S; Prempeh F; Habib MA; Schuerman L; Sorgho H; Agbenyega T
    Hum Vaccin Immunother; 2018 Jun; 14(6):1489-1500. PubMed ID: 29630438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The whole parasite, pre-erythrocytic stage approach to malaria vaccine development: a review.
    Epstein JE; Richie TL
    Curr Opin Infect Dis; 2013 Oct; 26(5):420-8. PubMed ID: 23982233
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progress with new malaria vaccines.
    Webster D; Hill AV
    Bull World Health Organ; 2003; 81(12):902-9. PubMed ID: 14997243
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.